PROVIDER PROFILE · NPI 1639129885

John LafrentzMD

OtolaryngologyHuntsville, ALI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

1,015

Unique beneficiaries

—

Total services

1,207

Distinct HCPCS

Medicare payment

$59K

Peer benchmark

Total Medicare services vs. 141 Otolaryngology providers in AL — below median (cohort median 1,570).

PRESCRIBING · PART D · 2024

Total Rx claims

377

Beneficiaries

—

Total drug cost

$7K

Distinct drugs

Brand share

8.2%

Top prescribed drugs

Azelastine Hcl89 claims

Fluticasone Propionate65 claims

Famotidine58 claims

Mupirocin36 claims

Ipratropium Bromide34 claims

QUALITY · MIPS · 2024

Final MIPS score

75.0

Quality

0.0

Cost

0.0

Improvement activities

0.0

Promoting interop.

0.0

Payment adjustment

0.00%

Group

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$218

Payment records

By payment type

Food and Beverage$218

REFERRAL NETWORK

Where John Lafrentz's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 6 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
THE HEALTH CARE AUTHORITY OF THE CITY OF HUNTSVILLE	126	260
LILES, JAN	103	167
CRESTWOOD HEALTHCARE LP	100	271
Laboratory Corporation Of America Holdings Clinical Laboratory · Birmingham, AL	24	37
Hung-Chi Kwok Anesthesiology · Huntsville, AL	17	40
Olaoluwa Odofin Internal Medicine · Huntsville, AL	14	39

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history